Moreover, the results of this study suggest the following clinical message: an admission myoglobin greater than 1200 μg/L predicts not only AKI (KDIGO 2 or 3) with sensitivity and specificity of 74 and 77%, respectively, but also severe rhabdomyolysis (occurrence of a CK peak greater than 5000 U/L) with sensitivity and specificity of 84 and 90%, respectively. This evidence concerns the gene MB and rhabdomyolysis.